What are the signs and symptoms of diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Diabetic Ketoacidosis (DKA)

Diabetic ketoacidosis presents with a characteristic pattern of symptoms including polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain, dehydration, weakness, clouding of sensoria, and in severe cases, coma. 1

Clinical Presentation

Cardinal Symptoms

  • Polyuria (excessive urination)
  • Polydipsia (excessive thirst)
  • Polyphagia (excessive hunger)
  • Weight loss
  • Dehydration with poor skin turgor

Gastrointestinal Symptoms

  • Nausea and vomiting (occurs in up to 25% of DKA patients) 1
  • Abdominal pain (characteristic of DKA but not HHS) 1
  • Coffee-ground emesis may be present and guaiac positive (related to hemorrhagic gastritis) 1

Respiratory Findings

  • Kussmaul respirations (deep, rapid breathing) - distinctive sign of DKA 1
  • Fruity breath odor (due to acetone) 2

Neurological Manifestations

  • Mental status changes ranging from full alertness to profound lethargy 1
  • Clouding of sensoria progressing to coma in severe cases 1
  • Stupor/coma in severe DKA (pH <7.00) 3

Cardiovascular Signs

  • Tachycardia
  • Hypotension
  • Signs of shock in advanced cases 1

Laboratory Findings

DKA is diagnosed based on the following criteria:

  • Blood glucose >250 mg/dL (though euglycemic DKA can occur) 4
  • Arterial pH <7.3 or serum bicarbonate <15 mEq/L 1
  • Moderate ketonemia or ketonuria 4

Severity Classification

Parameter Mild Moderate Severe
Arterial pH 7.25-7.30 7.00-7.24 <7.00
Bicarbonate (mEq/L) 15-18 10-14 <10
Mental Status Alert Alert/drowsy Stupor/coma

Timing of Symptom Development

DKA typically develops more rapidly than hyperosmolar hyperglycemic state (HHS):

  • DKA: Develops over hours to days (typically <24h) 1
  • HHS: Evolves over several days to weeks 1

Risk Factors and Precipitating Factors

Common Precipitating Factors

  • Infection (most common, occurring in 30-50% of cases) 5
  • Discontinuation or inadequate insulin in established type 1 diabetes 1
  • New-onset type 1 diabetes 1
  • Medications affecting carbohydrate metabolism (corticosteroids, thiazides, sympathomimetic agents) 1
  • Acute medical events (cerebrovascular accident, alcohol abuse, pancreatitis, myocardial infarction, trauma) 1
  • Psychological stress and eating disorders (in up to 20% of recurrent DKA cases in young patients) 1

Warning Signs Requiring Immediate Medical Attention

Patients should seek immediate medical attention if they experience:

  • Blood glucose >350 mg/dL with symptoms of metabolic decompensation 3
  • Inability to tolerate oral hydration 1
  • Blood glucose levels not improving with insulin administration 1
  • Altered mental status 1
  • Signs of worsening illness 1

Important Considerations

  • Patients may be normothermic or even hypothermic despite infection due to peripheral vasodilation 1
  • Hypothermia is a poor prognostic sign 1
  • DKA can occur in both type 1 and type 2 diabetes, though it's more common in type 1 5
  • One-third of hyperglycemic emergencies have a hybrid DKA-HHS presentation 1
  • Patients at risk for DKA should measure urine or blood ketones when glucose levels exceed 200 mg/dL, especially during illness or after missed insulin doses 1

Early recognition of these signs and symptoms is crucial for prompt treatment and prevention of life-threatening complications of DKA, which has a mortality rate of approximately 5% in experienced centers 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Ketoacidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.